Compound 1081
Identifiers
- Canonical SMILES:
CNc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F
- InChi:
InChI=1S/C24H21Cl2F2N5O/c1-29-24-32-31-23(34-24)20-21(14-10-11-17(27)16(26)12-14)33(18-9-5-8-15(25)19(18)28)22(30-20)13-6-3-2-4-7-13/h5,8-13H,2-4,6-7H2,1H3,(H,29,32)
- InChiKey:
ANDKHKGFXJCTPB-UHFFFAOYSA-N
External links
![]() 67954182 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.05 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 503.11 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 5.82 | |||
TPSA | 68.77 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 344 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 8.05 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4706 | Azeliragon | DB12689 | |
0.4352 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4281 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4254 | LY-2584702 | DB12690 | |
0.4015 | Ralimetinib | DB11787 | |
0.3958 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
0.3923 | Gluco-Phenylimidazole | DB02862 | |
0.3915 | Otenabant | DB11745 | |
0.3910 | Losartan | DB00678 | |
0.3879 | Velpatasvir | DB11613 | |
0.3846 | Olmesartan | DB00275 | |
0.3795 | Selonsertib | DB14916 | |
0.3724 | Elbasvir | DB11574 | |
0.3716 | Atorvastatin | DB01076 | |
0.3712 | N-6022 | DB12206 |